Catherine T. Doherty
At a glance: Catherine T. Doherty is President at Quest Diagnostics (DGX). Their latest SEC Form 4, filed Nov 5, 2026, reported a sale of $937K. On file: 0 purchase lines ($0) and 15 sale lines ($12.4M).
Disclosed holdings: about $18.6M of DGX stock: 71,949 shares reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 19, 2026 close of $259.06. This counts only DGX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp, Regional Businesses at Quest Diagnostics Inc (DGX); President at Quest Diagnostics Inc (DGX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Catherine T. Doherty's InsiderPrint
15 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 15 times a year, typically $725K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (15)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- John F. PaoliniChief Medical Officer · KNSA · 100% match
- Allan C. ThygesenCEO, President · DOCU · 100% match
- Ed HallenDirector · KVYO · 100% match
- Louise Frederika KooijChief Accounting Officer · NAMS · 100% match
- GM Enterprises, LLC10% Owner · LUNR · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 5SEC | DGXQuest Diagnostics Inc | Sell Plan | 3,81890,236 held (−4%) | $245.45 | $937K | +5.5% |
| Nov 5SEC | DGXQuest Diagnostics Inc | Sell Plan | 5,99084,246 held (−7%) | $246.26 | $1.5M | +5.2% |
| Nov 5SEC | DGXQuest Diagnostics Inc | Sell Plan | 1,15183,095 held (−1%) | $246.98 | $284K | +4.9% |
| Nov 5SEC | DGXQuest Diagnostics Inc | Sell Plan | 2,35880,737 held (−3%) | $248.38 | $586K | +4.3% |
| Nov 5SEC | DGXQuest Diagnostics Inc | Sell Plan | 3,00477,733 held (−4%) | $249.40 | $749K | +3.9% |
| Nov 5SEC | DGXQuest Diagnostics Inc | Sell Plan | 2,87774,856 held (−4%) | $250.49 | $721K | +3.4% |
| Nov 5SEC | DGXQuest Diagnostics Inc | Sell Plan | 2,90771,949 held (−4%) | $251.24 | $730K | +3.1% |
| Mar 6SEC | DGXQuest Diagnostics Inc | Sell Plan | 5,55867,122 held (−8%) | $206.21 | $1.1M | +25.6% |
| Mar 4SEC | DGXQuest Diagnostics Inc | Sell Plan | 63267,122 held (−1%) | $207.73 | $131K | +24.7% |
| Feb 20SEC | DGXQuest Diagnostics Inc | Sell Plan | 1,43368,402 held (−2%) | $204.83 | $294K | +26.5% |
| Feb 17SEC | DGXQuest Diagnostics Inc | Sell Plan | 10,57383,660 held (−11%) | $205.21 | $2.2M | +26.2% |
| Feb 17SEC | DGXQuest Diagnostics Inc | Sell Plan | 10,12273,538 held (−12%) | $206.37 | $2.1M | +25.5% |
| Feb 17SEC | DGXQuest Diagnostics Inc | Sell Plan | 3,50070,038 held (−5%) | $207.08 | $725K | +25.1% |
| Feb 17SEC | DGXQuest Diagnostics Inc | Sell Plan | 1,61968,419 held (−2%) | $208.21 | $337K | +24.4% |
| Feb 17SEC | DGXQuest Diagnostics Inc | Sell Plan | 35168,068 held (−1%) | $209.10 | $73K | +23.9% |
- Sell
President Catherine T. Doherty sold $937K of DGX at $245.45 — pre-scheduled 10b5-1 plan sale.
- Sell
President Catherine T. Doherty sold $1.5M of DGX at $246.26 — pre-scheduled 10b5-1 plan sale.
- Sell
President Catherine T. Doherty sold $284K of DGX at $246.98 — pre-scheduled 10b5-1 plan sale.
- Sell
President Catherine T. Doherty sold $586K of DGX at $248.38 — pre-scheduled 10b5-1 plan sale.
- Sell
President Catherine T. Doherty sold $749K of DGX at $249.40 — pre-scheduled 10b5-1 plan sale.
- Sell
President Catherine T. Doherty sold $721K of DGX at $250.49 — pre-scheduled 10b5-1 plan sale.
Follow Catherine T. Doherty
Get one email when Catherine T. Doherty files a new purchase or sale. Free.
At most one email a day about Catherine T. Doherty, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.